CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE Virtual Screening at the post-genomic era Dr. Didier ROGNAN Bioinformatic Group UMR CNRS 7081 Illkirch, France.

Slides:



Advertisements
Similar presentations
L. Brillet (CEA) – ANR meeting – META08 Hammamet 1/18 validation ANR meeting - 28/10/2008 CEA Grenoble - DSV/iRTSV/CMBA.
Advertisements

Design of high-content and focused libraries to improve the development of new active compounds in the framework of the rational drug discovery Design.
AutoDock 4 and AutoDock Vina -Brief Intruction
3D Molecular Structures C371 Fall Morgan Algorithm (Leach & Gillet, p. 8)
CH 328 Biomolecular Modelling Instructors: R. Woods, E. Fadda Schedule: Lectures (24) Wednesday / Thursday 9-10 am Dillon Theatre Computer labs (24) Monday.
Overview of Key ICM Features NIBR - Emeryville July
Improving enrichment rates A practical solution to an impractical problem Noel O’Boyle Cambridge Crystallographic Data Centre
Jürgen Sühnel Institute of Molecular Biotechnology, Jena Centre for Bioinformatics Jena / Germany Supplementary Material:
Computational Drug Design Apr 2010 Postgrad course on Comp Chem Noel M. O’Boyle.
How to approximate complex physical and thermodynamic interactions? Employ rigid or flexible structures for ligand and receptor (Side-chains or Back-bone.
Establishing a Successful Virtual Screening Process Stephen Pickett Roche Discovery Welwyn.
Molecular Docking G. Schaftenaar Docking Challenge Identification of the ligand’s correct binding geometry in the binding site ( Binding Mode ) Observation:
Two Examples of Docking Algorithms With thanks to Maria Teresa Gil Lucientes.
M. Wagener 3D Database Searching and Scaffold Hopping Markus Wagener NV Organon.
FLEX* - REVIEW.
Development and Validation of a Genetic Algorithm for Flexible Docking Gareth Jones, Peter Willet, Robert C. Glen, Andrew R. Leach and Robin Taylor J.
An Integrated Approach to Protein-Protein Docking
BL5203: Molecular Recognition & Interaction Lecture 5: Drug Design Methods Ligand-Protein Docking (Part I) Prof. Chen Yu Zong Tel:
Molecular modelling / structure prediction (A computational approach to protein structure) Today: Why bother about proteins/prediction Concepts of molecular.
Molecular Docking Using GOLD Tommi Suvitaival Seppo Virtanen S Basics for Biosystems of the Cell Fall 2006.
Chemoinformatics in Molecular Docking and Drug Discovery.
Protein-protein and Protein- ligand Docking The geometric filtering.
Protein Structure and Drug Discovery Workshop To be held at Monash University, Mebourne, Australia October 3 rd to 4 th 2006 Molecular Visualization Learn.
LSM2104/CZ2251 Essential Bioinformatics and Biocomputing Essential Bioinformatics and Biocomputing Protein Structure and Visualization (3) Chen Yu Zong.
Inverse Kinematics for Molecular World Sadia Malik April 18, 2002 CS 395T U.T. Austin.
Comparative Evaluation of 11 Scoring Functions for Molekular Docking Authors: Renxiao Wang, Yipin Lu and Shaomeng Wang Presented by Florian Lenz.
eHiTS Score Darryl Reid, Zsolt Zsoldos, Bashir S. Sadjad, Aniko Simon, The next stage in scoring function evolution: a new statistically.
QSAR Qualitative Structure-Activity Relationships Can one predict activity (or properties in QSPR) simply on the basis of knowledge of the structure of.
Computational Techniques in Support of Drug Discovery October 2, 2002 Jeffrey Wolbach, Ph. D.
Molecular Docking S. Shahriar Arab. Overview of the lecture Introduction to molecular docking: Definition Types Some techniques Programs “Protein-Protein.
23 May June May 2002 From genes to drugs via crystallography 19 May 1996 Experimental and computational approaches to structure based.
BIOC3010: Bioinformatics - Revision lecture Dr. Andrew C.R. Martin
Asia’s Largest Global Software & Services Company Genomes to Drugs: A Bioinformatics Perspective Sharmila Mande Bioinformatics Division Advanced Technology.
ClusPro: an automated docking and discrimination method for the prediction of protein complexes Stephen R. Comeau, David W.Gatchell, Sandor Vajda, and.
A genetic algorithm for structure based de-novo design Scott C.-H. Pegg, Jose J. Haresco & Irwin D. Kuntz February 21, 2006.
 Four levels of protein structure  Linear  Sub-Structure  3D Structure  Complex Structure.
Faculté de Chimie, ULP, Strasbourg, FRANCE
Flexible Multi-scale Fitting of Atomic Structures into Low- resolution Electron Density Maps with Elastic Network Normal Mode Analysis Tama, Miyashita,
BL5203 Molecular Recognition & Interaction Section D: Molecular Modeling. Chen Yu Zong Department of Computational Science National University of Singapore.
In silico discovery of inhibitors using structure-based approaches Jasmita Gill Structural and Computational Biology Group, ICGEB, New Delhi Nov 2005.
Page 1 SCAI Dr. Marc Zimmermann Department of Bioinformatics Fraunhofer Institute for Algorithms and Scientific Computing (SCAI) Grid-enabled drug discovery.
SimBioSys Inc.© Slide #1 Enrichment and cross-validation studies of the eHiTS high throughput screening software package.
SimBioSys Inc.© 2004http:// Conformational sampling in protein-ligand complex environment Zsolt Zsoldos SimBioSys Inc., © 2004 Contents:
Altman et al. JACS 2008, Presented By Swati Jain.
Virtual Screening C371 Fall INTRODUCTION Virtual screening – Computational or in silico analog of biological screening –Score, rank, and/or filter.
Bioinformatics MEDC601 Lecture by Brad Windle Ph# Office: Massey Cancer Center, Goodwin Labs Room 319 Web site for lecture:
Hierarchical Database Screenings for HIV-1 Reverse Transcriptase Using a Pharmacophore Model, Rigid Docking, Solvation Docking, and MM-PB/SA Junmei Wang,
R L R L L L R R L L R R L L water DOCKING SIMULATIONS.
Structure- based Structure-based computer-aided drug discovery (SB-CADD) approach: helps to design and evaluate the quality, in terms of affinity, of series.
Surflex: Fully Automatic Flexible Molecular Docking Using a Molecular Similarity-Based Search Engine Ajay N. Jain UCSF Cancer Research Institute and Comprehensive.
Molecular mechanics Classical physics, treats atoms as spheres Calculations are rapid, even for large molecules Useful for studying conformations Cannot.
Elon Yariv Graduate student in Prof. Nir Ben-Tal’s lab Department of Biochemistry and Molecular Biology, Tel Aviv University.
Docking and Virtual Screening Using the BMI cluster
Molecular Modeling in Drug Discovery: an Overview
Natural products from plants
Structure-based inhibitor design and validation: Application to Plasmodium falciparum glutathione S-transferase Marli Botha MSc. Bioinformatics.
Structural Bioinformatics Elodie Laine Master BIM-BMC Semester 3, Genomics of Microorganisms, UMR 7238, CNRS-UPMC e-documents:
Page 1 Computer-aided Drug Design —Profacgen. Page 2 The most fundamental goal in the drug design process is to determine whether a given compound will.
APPLICATIONS OF BIOINFORMATICS IN DRUG DISCOVERY
Molecular Docking Profacgen. The interactions between proteins and other molecules play important roles in various biological processes, including gene.
International Chemical Design & Discovery Course 2017
Virtual Screening.
“Structure Based Drug Design for Antidiabetics”
Ligand Docking to MHC Class I Molecules
An Integrated Approach to Protein-Protein Docking
Reporter: Yu Lun Kuo (D )
Mr.Halavath Ramesh 16-MCH-001 Dept. of Chemistry Loyola College University of Madras-Chennai.
Mr.Halavath Ramesh 16-MCH-001 Dept. of Chemistry Loyola College University of Madras-Chennai.
Mr.Halavath Ramesh 16-MCH-001 Dept. of Chemistry Loyola College University of Madras-Chennai.
Mr.Halavath Ramesh 16-MCH-001 Dept. of Chemistry Loyola College University of Madras-Chennai.
Presentation transcript:

CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE Virtual Screening at the post-genomic era Dr. Didier ROGNAN Bioinformatic Group UMR CNRS 7081 Illkirch, France

CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE Virtual screening: Definition Searching electronic databases (2D, 3D) for molecules fitting: a pharmacophore an active site Walters et al. Drug Discovery Today 1998, 3, Schneider et al., Drug Discovery Today 2002, 7,

CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE Sci Scientific reasons ntific reasons 1.Increasing number of interesting macromolecular targets (500  10,000) 2.Increasing number of protein 3-D structures (X-ray, NMR) 3.Better knowledge of protein-ligand interactions 4.Dévelopement of chem- and bio-informatic methods 5.Increasing computing facilities Economic reasons 1.High cost of high-througput screening (HTS): 0.2 € /molecule 2.Increase the ratio ions Applications 1.Identifying the very first ligands of orphan targets 2.Identifying/optimizing new chemical scaffolds Importance of virtual screening # of active molecules (hits) # of tested molecules

CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE Protein-based virtual screening 2. Evaluation « Scoring » Mol #  G bind Database (3-D) 1. Orientation « docking » Target-Ligand Complex Target (3D !!) Hit list

CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE Docking Goal Quickly find (1-2 min./molécule)  the orientation of the ligand in the active site  the protein-bound conformation Méthods Orientation  Surface complementarity  Complementarity of intermolecular interactions Conformational freedom  Incremental construction  Conformational sampling (MC, GA, SA) Abagyan et al. Curr. Opin. Struct. Biol. 2001, 5,

CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE Docking : Orientation Surface-based orientation (e.g. DOCK) 2. Molecular surface (active site) 3. Filling the surface by overlapping spheres 4. Matching sphere centers with atoms 1. 3D structure

CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE Docking : Orientation interactions-based orientation (e.g. FlexX) -Statistical rules for locating ligand atoms -Overall placement of a base fragment by triangulation

CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE Docking: Ligand flexibility - by preselecting several conformers/molecules - by incremental construction Termination adding the 2ndadding the 1st peripheral fragment peripheral fragment Reading preferred torsion values Selecting the « best » Ligand Fragment decomposition base fragment

CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE - by a genetic algorithm (e.g. Gold) Initial population Selection of parents Genetic operators Selection of children New population Convergence test size Parent Score A2.5 B5.0 C1.5 D1.0 B A C D Survival rate gene: x,y,z coords. tors. angles orientation … crossing over mutation New generation crossing over rate mutation rate # of evolutions Chromosome = Ligand (orientation, conformation) Docking: Ligand flexibility

CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE Docking Accuracy Analysing 100 high-resolution PDB complexes Paul,N. and Rognan, D. Proteins, in press Finding a reliable pose out of a set of solutions is feasible !

CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE Docking Accuracy Analysing 100 high-resolution PDB complexes Paul,N. and Rognan, D. Proteins, in press Ranking the most reliable solution at the top of the list is still an issue !

CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE Source of Docking Errors Nature of the active site (flat vs. cavity) Missed influence of water Ligand flexibility Inaccuracy of the scoring function Unusual binding mode/interactions Inadequate set of protein coordinates Wrong atom typing Impossible Difficult Easy

CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE Scoring Thermodynamic Methods: FEP, TI (2) Force-fields (10-100) QSAR, 3D-QSAR (100-1,000) Empirical scoring functions (>100,000) # of molecules Error, kJ/mol Accuracy ,

CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE Scoring First-principle methods: sum of physically meaningfull terms Regression-based free energy approximations: sum of regression-weighted terms Potential of mean forces distance-dependent atom pair-weighted Helmotz free energies Gohlke et al. Curr. Opin. Struct. Biol. 2001, 11,

CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE Empirical Scoring function Constant H-bond term g 1 (  r) =       )/0.4-r(1 1 Å 0.65 r if Å 0.65 r Å 0.25 if 0.25År if    g 2 (  ) =       0 30)/50-α ( 1 1 º80 α if 80º α 30º if º03α    f(r) =       0 R1)/3.-r(1 1 R2 r if R2r R1 if R1r if    lipophilic term buried-polar repulsive term rotational term desolvation term Fresno Rognan et al. (1999) J. Med. Chem., 42,

CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE Scoring Accuracy Current accuracy: 5-10 kJ/mol (1-2 pK unit) Weak point of all docking programs Entropic contributions are difficult to handle ! ! Way-around: use of consensus scoring functions

CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE Isis/Base 2-D Fingerprint Full database Filtering Chemical reactivty pharmacokinétics Drug-likeness Filtered database 2D  3D Hydrogens Ionisation 3-D Database Library set-up

CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE Applications High-resolution X-ray structures (enzymes) TargetLigands BaseHit Reference Rate CD4-gp120inhibitors 150, % Li et al., PNAS (1997) gp41inhibitors 20, % Debnath et al., J. Med. Chem. (1999) FTinhibitors 219, % Perola et al., J. Med. Chem (2000) kinesininhibitors 20, % Hopkins et al., Biochemistry (2000) HIV1 Tar-Tatinhibitors 153, % Filikov et al., JCAMD (2000) gp41inhibitors 20, % Debnath et al., J. Med. Chem Bcl-2inhibitors 207, % Enyedi et al., J. Med. Chem (2001) HCA-IIinhibitors 90, % Grüneberg et al., Angew. (2001) RARagonists 250, % Shapira et al., BMC Struct. Biol. (2001) TPIinhibiteurs 108, % Joubert et al., Proteins (2001) ER  antagonists 1,500, % Shapira et al. IBM Sys. J. (2001) FT: farnesyltransférase, HCA: human carbonic anhydrase, RAR: retonic acid receptor, ER: Estrogen receptor, TPI: triosephosphate isomerase, PEP: phosphoenolpyruvate

CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE Conclusions What is possible ? Discriminate true hits from random ligands Enriching a reduced library by a factor 20 Retrieving about 50% of all true hits Prioritizing ligands for synthesis and experimental screening Using virtual screening for lead finding What remains to improve ? Predicting the exact orientation Predicting the absolute binding free energy Discriminating true hits from “similar inactives“ Catching all hits Using virtual screening for lead optimization Throughput (100K mols/day  1M/day ?) Pre and post-processing of vHTS

CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE Virtual screening at the genomic scale Primary Sequence 3-D Model virtual Hits True Hits Sélectivity Affinity ADME/Tox GPCR-Gen vHTS Validation Available analogues Focussed Libraries vs. Enzymes (PDB library) vs. RCPGs (RCPG library) e-Libraries “Bioinfo” (350,000) “RCPG” ( 30,000) “Endo” ( 2,000) Optimisation RCPGs of the human genome

CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE molecules virtual Library (10 8 conformations) 10 5 (10 6 conformations) ADME/Tox Similarité 2-D Conformations 3-D Similarity 3-D Docking Scoring expt. Validation True hits Virtual screening: Tomorrow